FI940224A - Ophthalmic compositions containing oxicam or oxicam derivatives - Google Patents

Ophthalmic compositions containing oxicam or oxicam derivatives Download PDF

Info

Publication number
FI940224A
FI940224A FI940224A FI940224A FI940224A FI 940224 A FI940224 A FI 940224A FI 940224 A FI940224 A FI 940224A FI 940224 A FI940224 A FI 940224A FI 940224 A FI940224 A FI 940224A
Authority
FI
Finland
Prior art keywords
oxicam
compositions containing
ophthalmic compositions
derivatives
compositions
Prior art date
Application number
FI940224A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI940224A0 (en
FI107700B (en
Inventor
Gerard Schwadrohn
Original Assignee
Europhta Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Europhta Lab filed Critical Europhta Lab
Publication of FI940224A0 publication Critical patent/FI940224A0/en
Publication of FI940224A publication Critical patent/FI940224A/en
Application granted granted Critical
Publication of FI107700B publication Critical patent/FI107700B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Novel pharmaceutical compositions for ophthalmic use, particularly instillable ophthalmic compositions having average viscosity and characterized in that they contain, as the active principle, an anti-flammatory agent which is optionally combined with an antibacterial agent, a gellable acrylic acid polymer and a basic agent to form a fluid aqueous solute with a pH of 7.0-8.0. The compositions are useful for treating inflammatory diseases of the eyeball.
FI940224A 1991-07-18 1994-01-17 Process for the preparation of ophthalmic compositions FI107700B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9109096A FR2679135B1 (en) 1991-07-18 1991-07-18 NOVEL OPHTHALMIC COMPOSITIONS WITH IMPROVED ADHESIVITY AND METHODS OF PREPARING THE SAME.
FR9109096 1991-07-18
PCT/FR1992/000696 WO1993001814A1 (en) 1991-07-18 1992-07-17 Oxicam or oxicam derivatives-containing ophthalmic compositions
FR9200696 1992-07-17

Publications (3)

Publication Number Publication Date
FI940224A0 FI940224A0 (en) 1994-01-17
FI940224A true FI940224A (en) 1994-03-14
FI107700B FI107700B (en) 2001-09-28

Family

ID=9415269

Family Applications (1)

Application Number Title Priority Date Filing Date
FI940224A FI107700B (en) 1991-07-18 1994-01-17 Process for the preparation of ophthalmic compositions

Country Status (10)

Country Link
EP (1) EP0594770B1 (en)
AT (1) ATE147627T1 (en)
AU (1) AU2388392A (en)
DE (1) DE69216831T2 (en)
DK (1) DK0594770T3 (en)
ES (1) ES2099272T3 (en)
FI (1) FI107700B (en)
FR (1) FR2679135B1 (en)
NO (1) NO940160L (en)
WO (1) WO1993001814A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19511322C2 (en) * 1995-03-28 1999-09-02 Mann Gerhard Chem Pharm Fab Sterile eye gels containing medium chain triglycerides and process for their preparation
JP2001513563A (en) * 1997-08-27 2001-09-04 ヘキサル アーゲー Pharmaceutical composition of meloxicam with improved solubility and bioavailability
GB9718568D0 (en) 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
KR100627620B1 (en) * 1998-05-15 2006-09-25 와카모토 세이야꾸 가부시끼가이샤 Anti-inflammatory eye drops
WO2001037838A1 (en) * 1999-11-24 2001-05-31 Wakamoto Pharmaceutical Co., Ltd. Ophthalmic aqueous preparation
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (en) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Highly concentrated stable meloxicam solutions for needleless injection
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
BR0318395A (en) * 2003-07-10 2006-08-01 Arturo Jimenez Bayardo method for preparing an aqueous meloxicam solution and the resulting aqueous solution
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
BRPI0720434A2 (en) 2006-12-22 2014-01-07 Sigma Tau Ind Farmaceuti USEFUL GEL FOR OPHTHALMIC PHARMACEUTICAL RELEASE
CN102647971B (en) 2009-10-12 2016-03-16 贝林格尔.英格海姆维特梅迪卡有限公司 For comprising the container of the compositions of meloxicam
SG183846A1 (en) 2010-03-03 2012-10-30 Boehringer Ingelheim Vetmed Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056684B2 (en) * 1977-11-07 1985-12-11 東興薬品工業株式会社 eye drops
JPS5913714A (en) * 1982-07-13 1984-01-24 Taito Pfizer Kk Antiphlogistic and analgesic agent for external use

Also Published As

Publication number Publication date
DK0594770T3 (en) 1997-07-21
WO1993001814A1 (en) 1993-02-04
FI940224A0 (en) 1994-01-17
DE69216831T2 (en) 1997-07-31
NO940160L (en) 1994-03-04
AU2388392A (en) 1993-02-23
DE69216831D1 (en) 1997-02-27
FI107700B (en) 2001-09-28
EP0594770B1 (en) 1997-01-15
FR2679135A1 (en) 1993-01-22
NO940160D0 (en) 1994-01-17
ES2099272T3 (en) 1997-05-16
FR2679135B1 (en) 1995-05-19
ATE147627T1 (en) 1997-02-15
EP0594770A1 (en) 1994-05-04

Similar Documents

Publication Publication Date Title
FI940224A (en) Ophthalmic compositions containing oxicam or oxicam derivatives
FR2329261A1 (en) EYE INSERTION BODY FOR THE TREATMENT OF EYE DRYCITIS BY AQUEOUS DEFICIENCY
DK0418339T3 (en) Preparation and Method for Preventing Tissues Between Body Tissues
ES8802091A1 (en) Improved disinfecting and preserving solutions for contact lenses and methods of use.
DK0495421T3 (en) Use of carrageenans in topical ophthalmic compositions
TR199800436A2 (en) Use of pyrimidine derivatives for cancer prevention.
CA2010786A1 (en) Surfactant combination
BR9914128A (en) Antibiotic compositions for treatment of the eye, ear and nose
AR024380A1 (en) TIENOPIRIMIDINES
ATE182586T1 (en) PHARMACOLOGICAL USE OF 5-AMINOPHTHHALOYLHYDRAZIDE; THEIR COMPOSITION AND APPLICATION
ES2132241T3 (en) OPHTHALMIC COMPOSITIONS AND METHODS FOR CONSERVATION AND USE.
DE69526369D1 (en) ANTI-INFLAMMATORY EYE DROPS
DK0560730T3 (en) Amino acid derivatives with antithrombotic effect
SE8801710L (en) NEW OPHTALMOLOGICAL COMPOSITION OF MATTER
FI940081A (en) Polyacrylic-based compositions for eye inflammation
ATE185696T1 (en) OPHTALMIC COMPOSITIONS CONTAINING EMEDASTINE AND THEIR USE FOR THE TREATMENT OF ALLERGIC CONJUNCTIVITIS
ATE337002T1 (en) TOPICAL TREATMENT TO PREVENT EYE INFECTIONS
MC2217A1 (en) PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR OPTALMOLOGICAL USE CONTAINING HEXETIDINE OR ITS DERIVATIVES OR SALTS
ES2060103T3 (en) HYDROPHILIC AMPHOLYTE POLYMERS, THEIR PREPARATION PROCEDURE, AND THEIR USE AS ABSORBENT AGENTS.
DE69115890D1 (en) STERILIZING COMPOSITION
RU93015155A (en) MEDICINE FOR THE TREATMENT OF DYSTROPHIC DISEASES AND INJURIES OF THE EYE TISSUES
TH58970B (en) Formula for use on eyes
CA1273296C (en) Soluble collagen composition

Legal Events

Date Code Title Description
MA Patent expired